Gene: SCYGR10
Official Full Name: small cysteine and glycine repeat containing 10 (gene/pseudogene)provided by HGNC
Gene Summary: This gene is a member of a large gene family that encodes keratin associated proteins (KRTAP) that play a role in hair formation. This gene belongs to a subfamily of the KRTAP family termed small cysteine and glycine repeat containing (SCYGR) genes and it resides in a cluster of SCYGR genes on chromosome 2q36.3. Allelic polymorphisms in this gene result in both coding and non-coding transcripts; the reference genome represents the non-coding allele. [provided by RefSeq, Jan 2024]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14272 | SCYGR10 Knockout cell line (HeLa) | Human | SCYGR10 | 1:3~1:6 | Negative | Online Inquiry |
KO14273 | SCYGR10 Knockout cell line (HCT 116) | Human | SCYGR10 | 1:2~1:4 | Negative | Online Inquiry |
KO14274 | SCYGR10 Knockout cell line (HEK293) | Human | SCYGR10 | 1:3~1:6 | Negative | Online Inquiry |
KO14275 | SCYGR10 Knockout cell line (A549) | Human | SCYGR10 | 1:3~1:4 | Negative | Online Inquiry |
SCYGR10 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to eliminate the expression of the SCYGR10 gene, a critical element involved in various cellular processes. These knockout cell lines serve as vital tools for elucidating gene function, understanding gene regulatory networks, and probing the underlying mechanisms of diseases associated with SCYGR10 dysregulation.
The primary mechanism of action revolves around CRISPR-Cas9 technology, which allows targeted editing of the SCYGR10 locus in the genome. This precise gene-editing approach ensures a complete knockout, resulting in the ablation of SCYGR10 protein expression. Consequently, researchers can assess phenotypic changes and cellular responses, enabling investigations into pathways influenced by SCYGR10 and its potential role in disease progression or therapeutic resistance.
The scientific importance of SCYGR10 Gene Knockout Cell Lines cannot be overstated, as they provide a framework for comprehensive research applications, including but not limited to cancer biology, neurobiology, and drug discovery. These cell lines allow researchers to generate reliable data that can lead to novel insights into therapeutics targeting SCYGR10-related pathways, thereby contributing substantially to translational medicine.
Compared to conventional cell line models, our SCYGR10 Gene Knockout Cell Lines offer unparalleled specificity and reproducibility, reducing variability often encountered in knockdown models. The inherent robustness of these lines, coupled with extensive validation, positions them as superior alternatives for research requiring genetic manipulation.
For researchers and clinicians seeking to deepen their understanding of SCYGR10’s role within biological systems, our product is invaluable. By integrating these knockout cell lines into their investigations, users can contribute to cutting-edge advancements in precision medicine and targeted therapies.
With our company's commitment to producing high-quality, reliable biological products backed by extensive expertise in genetic engineering and cell line development, SCYGR10 Gene Knockout Cell Lines exemplify our dedication to supporting the scientific community in their quest for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.